483
BASF CorporationFDA 483 - BASF Corporation - July 22, 2024
Record Details
An FDA inspection of BASF Corporation in Geismar, LA, an API manufacturer, revealed an observation regarding inadequate investigations. The firm failed to adequately investigate out-of-specification (OOS) iodine occurrences for its active pharmaceutical ingredient (API) PVP-Iodine. These investigations did not address the root cause or evaluate the impact on process controls.
Open in Dashboard
ID · 62f464e2-49f9-4484-b12c-1d3b480f7034